ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RNLX Renalytix PLC

0.4511
-0.0048 (-1.05%)
08 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Renalytix PLC RNLX NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-0.0048 -1.05% 0.4511 14:00:07
Open Price Low Price High Price Close Price Previous Close
0.4506 0.4501 0.46 0.451 0.4559
more quote information »

Recent News

Date Time Source Heading
06/6/202406:31EDGAR2Form S-3 - Registration statement under Securities Act of..
28/5/202421:15EDGAR2Form 8-K - Current report
16/5/202400:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/5/202423:23EDGAR2Form 8-K - Current report
15/5/202421:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202421:00EDGAR2Form 8-K - Current report
15/5/202421:00GLOBERenalytix Reports Financial Results for Third Quarter of..
09/5/202421:00GLOBERenalytix to Report Financial Results for Third Quarter..
08/4/202421:00GLOBERenalytix Announces Financing with Expected Size of up to $4..
14/3/202422:00GLOBEKidneyIntelX™ included in Final KDIGO 2024 Clinical..
15/2/202423:00GLOBERenalytix Reports Financial Results for Second Quarter of..
15/2/202423:00EDGAR2Form 8-K - Current report
15/2/202408:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/2/202401:00GLOBERenalytix to Participate in the BTIG MedTech, Digital..
17/1/202423:15EDGAR2Form 8-K - Current report
10/1/202423:15EDGAR2Form 8-K - Current report
10/1/202423:00GLOBENew published data demonstrates KidneyIntelX™ has broad..
30/12/202308:02EDGAR2Form 8-K - Current report
18/11/202308:01EDGAR2Form ARS - Annual Report to Security Holders
14/11/202323:00GLOBERenalytix Reports Financial Results for First Quarter of..
07/11/202323:00GLOBERenalytix to Report Financial Results for First Quarter..
04/11/202307:04EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202323:00EDGAR2Form 8-K - Current report
06/10/202322:00GLOBEUS Patent Office Allows Patent Claims for Intellectual..
28/9/202321:00GLOBERenalytix Reports Full Year Fiscal 2023 Results
25/9/202321:00GLOBERenalytix to Report Financial Results for Fourth Quarter and..
09/9/202306:04EDGAR2Form 8-K - Current report
07/9/202321:00GLOBERenalytix Appoints Senior Executive Howard Doran as Chief..
03/8/202321:00GLOBERenalytix Clinical Advisory Board Formed to Support..
21/7/202321:00GLOBERenalytix Announces Middle East Distribution Agreement with..
07/7/202321:00GLOBELate-Breaking KidneyIntelX Evidence Released at 83rd..
03/7/202321:00GLOBERenalytix Appoints Financial Executive Catherine Coste to..
30/6/202308:58DJNRenalytix Gets FDA De Novo Marketing Authorization for..
30/6/202308:01GLOBEFDA Grants De Novo Marketing Authorization for..
15/6/202321:00GLOBEKidneyIntelX™ Clinical Decision Impact / Validation and..
09/6/202321:00GLOBERenalytix Reports Financial Results for Third Quarter of..

Your Recent History

Delayed Upgrade Clock